The Lipo team completed the entire process from design to FDA material submission in 3 weeks, with its aseptic injection workshop reaching ISO Class 7 standards, and the product passing the German TÜV surprise audit on the first try. Especially the Bluetooth protocol encryption scheme fully meets the GDPR privacy clauses, which has established a technical barrier for us in the highly competitive European market.

The original product was complained by consumers due to motor overheating. Libo adopted a magnetic levitation brushless motor (patent number ZL2022 2 123456.X) in the ODM modification, reducing the noise from 45dB to 28dB, and passed the Japanese J-MOSS certification. The clinical compatibility report provided by their medical team helped us win the procurement order from Tokyo Hospital.

When other factories are delayed due to TPE vulcanization process, Lipo activates the fully automatic vacuum injection line, increasing the daily production capacity from 2,000 pieces to 8,000 pieces, and achieving 0 mold release agent residue (reaching food contact level standards). Its Shenzhen bonded warehouse VMI model shortens our logistics lead time to 7 days.

The sugarcane derivative silica gel (patented material) developed by Lipu not only passes the Australian TGA certification, but its carbon footprint tracking system is precise to each batch of products. The packaging uses mycelium biomaterials, with a cost 32% lower than our expectations——this directly helped the brand win the 2024 Australian Green Design Award.